NDC 72893-016

Ryzneuta 20 mg per 1 mL injection

On the label: Acrotech Biopharma Inc.

China: 2United States: 1

Where it's made

FactoryWhereRoleLast FDA inspection
Bio-Thera Solutions, Ltd.Guangzhou, ChinaMakes it, packages it and labels it Not inspected on record
Evive Biopharmaceutical (Beijing), Ltd.Beijing, ChinaMakes the active ingredient Not inspected on record
PCI San Diego, Inc.San Diego, CA, United StatesMakes it and tests it Problems found, fixed voluntarilyMay 9, 2025 · 11 inspections
Catalent Germany Schorndorf GmbHSchorndorf, GermanyPackages it and labels it Problems found, fixed voluntarilyMar 17, 2022 · 7 inspections
Eurofins Lancaster Laboratories, LLCLancaster, PA, United StatesTests it Problems found, fixed voluntarilyAug 26, 2025 · 8 inspections
FUJIFILM Diosynth Biotechnologies U.S.A., IncResearch Triangle Park, NC, United StatesTests it Problems found, fixed voluntarilyApr 21, 2021 · 5 inspections
WuXi Biologics Biosafety Testing (Suzhou) Co., Ltd.Suzhou, ChinaTests it Problems found, fixed voluntarilyFeb 2, 2024 · 1 inspection

Product details

Generic drug
Efbemalenograstim Alfa: every company that makes it
Form
injection, subcutaneous
Strength
20 mg per 1 mL
Approval
BLA BLA761134
On the market since
Nov 23, 2023
Package NDCs
72893-016-02
Official label
DailyMed (National Library of Medicine), updated Oct 20, 2026

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?